Effects of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and an eGFR below 30 ml/min/1.73 m2

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Novel treatment approaches in heart failure and cardiomyopathies Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by